Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

13,800

Employees13,800

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

13,800

Employees13,800

ZTS Key Statistics

Market cap

65.41B

Market cap65.41B

Price-Earnings ratio

25.16

Price-Earnings ratio25.16

Dividend yield

1.32%

Dividend yield1.32%

Average volume

2.50M

Average volume2.50M

High today

$147.72

High today$147.72

Low today

$146.29

Low today$146.29

Open price

$146.44

Open price$146.44

Volume

678.13K

Volume678.13K

52 Week high

$200.33

52 Week high$200.33

52 Week low

$139.70

52 Week low$139.70

ZTS News

Simply Wall St 3d

How EMA’s Positive Opinion on Portela Could Shape Zoetis's Innovation and Growth Potential

Earlier this week, Zoetis announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products has issued a positive opinion recommending...

TipRanks 4d

Zoetis announces positive opinion from CVMP for Portela

Zoetis (ZTS) announced that the Committee for Veterinary Medicinal Products of the European Medicines Agency has adopted a positive opinion recommending the gra...

Analyst ratings

80%

of 20 ratings

Buy

80%

Hold

20%

Sell

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.